The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 14, 2021
Filed:
Nov. 16, 2018
Applicant:
Landos Biopharma, Inc., Blacksburg, VA (US);
Inventors:
Josep Bassaganya-Riera, Blacksburg, VA (US);
Andrew Leber, Blacksburg, VA (US);
Raquel Hontecillas, Blacksburg, VA (US);
Assignee:
LANDOS BIOPHARMA, INC., Blacksburg, VA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61P 1/00 (2006.01); C12N 5/0783 (2010.01); A01K 67/027 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A01K 67/0276 (2013.01); A61P 1/00 (2018.01); C12N 5/0636 (2013.01); C12N 5/0637 (2013.01); A01K 2217/075 (2013.01); A01K 2217/15 (2013.01); A01K 2217/206 (2013.01); A01K 2227/105 (2013.01); A01K 2267/035 (2013.01); A61K 2035/122 (2013.01); C12N 2501/15 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2312 (2013.01); C12N 2501/385 (2013.01); C12N 2501/999 (2013.01);
Abstract
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway and cells, such as immune cells, prepared in vitro with the compounds. The compounds and cells can be used to treat a number of conditions, including infectious diseases, hyperproliferative disorders, inborn errors of metabolism, chronic immunometabolic diseases, autoimmune diseases, organ transplant rejection, inflammatory disorders, and chronic pain, among others.